13D/13G Filings - Soleus Capital Master Fund, L.P.

Real time Form 13D and 13G transaction reports:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
  • Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Time period
Goto Prev, 0, 1, 2, 3, Next
Reported
DateTime
Transaction
Date
Type Company
Symbol
Filed By
Symbol
Shares Owned
% Owned
Shares Vs. Prev Report View
2024-11-14
3:30 pm
Purchase
2024-09-30 13G C4 Therapeutics, Inc.
CCCC
Soleus Capital Master Fund, L.P. 6,603,996
9.400%
4,048,000increase
(+158.37%)
Filing
History
2024-06-07
08:30 am
Purchase
2024-06-06 13G Terns Pharmaceuticals, Inc.
TERN
Soleus Capital Master Fund, L.P. 3,341,120
5.200%
3,341,120increase
(New Position)
Filing
History
2024-02-09
10:32 am
Purchase
2023-12-31 13G Celcuity Inc.
CELC
Soleus Capital Master Fund, L.P. 2,623,890
9.900%
338,336increase
(+14.80%)
Filing
History
2024-02-08
10:08 am
Purchase
2024-02-05 13G CalciMedica, Inc.
CALC
Soleus Capital Master Fund, L.P. 1,105,016
9.990%
321,112increase
(+40.96%)
Filing
History
2024-02-05
10:24 am
Purchase
2024-01-26 13G C4 Therapeutics, Inc.
CCCC
Soleus Capital Master Fund, L.P. 2,555,996
5.200%
720,000increase
(+39.22%)
Filing
History
2024-02-02
09:59 am
Sale
2023-12-31 13G Pieris Pharmaceuticals, Inc.
PIRS
Soleus Capital Master Fund, L.P. 0
0.000%
-50,000decrease
(Position Closed)
Filing
History
2024-02-02
09:56 am
Purchase
2023-12-31 13G Rigel Pharmaceuticals, Inc.
RIGL
Soleus Capital Master Fund, L.P. 944,258
5.400%
21,956increase
(+2.38%)
Filing
History
2024-02-02
09:54 am
Purchase
2023-12-31 13G Organogenesis Holdings Inc.
ORGO
Soleus Capital Master Fund, L.P. 8,963,000
6.800%
1,599,937increase
(+21.73%)
Filing
History
2024-02-02
09:53 am
Sale
2023-12-31 13G Surmodics, Inc.
SRDX
Soleus Capital Master Fund, L.P. 771,700
5.400%
-3,611decrease
(-0.47%)
Filing
History
2024-02-02
09:50 am
Purchase
2023-12-31 13G Jasper Therapeutics, Inc.
JSPR
Soleus Capital Master Fund, L.P. 987,096
8.800%
987,096increase
(New Position)
Filing
History
2024-02-02
09:49 am
Purchase
2023-12-31 13G Verastem, Inc.
VSTM
Soleus Capital Master Fund, L.P. 1,425,634
6.800%
128,265increase
(+9.89%)
Filing
History
2024-02-02
09:44 am
Sale
2023-12-31 13G IRadimed Corporation
IRMD
Soleus Capital Master Fund, L.P. 643,206
5.100%
-101,798decrease
(-13.66%)
Filing
History
2024-02-02
09:42 am
Sale
2023-12-31 13G VYNE Therapeutics Inc.
VYNE
Soleus Capital Master Fund, L.P. 703,868
5.000%
-187,000decrease
(-20.99%)
Filing
History
2024-02-02
09:41 am
Purchase
2023-12-31 13G EDAP TMS S.A.
EDAP
Soleus Capital Master Fund, L.P. 7,226,341
19.600%
2,091,911increase
(+40.74%)
Filing
History
2024-02-02
09:37 am
Sale
2023-12-31 13G Delcath Systems, Inc.
DCTH
Soleus Capital Master Fund, L.P. 0
0.000%
-806,420decrease
(Position Closed)
Filing
History
2024-02-02
09:34 am
Sale
2023-12-31 13G C4 Therapeutics, Inc.
CCCC
Soleus Capital Master Fund, L.P. 1,835,996
3.700%
-626,024decrease
(-25.43%)
Filing
History
2024-02-02
09:29 am
Sale
2023-12-31 13G AxoGen, Inc.
AXGN
Soleus Capital Master Fund, L.P. 2,595,815
6.000%
-945,483decrease
(-26.70%)
Filing
History
2024-01-26
4:15 pm
Purchase
2024-01-23 13G CalciMedica, Inc.
CALC
Soleus Capital Master Fund, L.P. 783,904
7.400%
783,904increase
(New Position)
Filing
History
2023-11-28
4:52 pm
Purchase
2023-11-27 13D Theratechnologies Inc.
THTX
Soleus Capital Master Fund, L.P. 5,188,876
10.500%
5,188,876increase
(New Position)
Filing
History
2023-11-02
4:15 pm
Purchase
2023-11-01 13G VYNE Therapeutics Inc.
VYNE
Soleus Capital Master Fund, L.P. 890,868
6.400%
890,868increase
(New Position)
Filing
History
Goto Prev, 0, 1, 2, 3, Next